ECSP066411A - Tienopirazoles - Google Patents

Tienopirazoles

Info

Publication number
ECSP066411A
ECSP066411A EC2006006411A ECSP066411A ECSP066411A EC SP066411 A ECSP066411 A EC SP066411A EC 2006006411 A EC2006006411 A EC 2006006411A EC SP066411 A ECSP066411 A EC SP066411A EC SP066411 A ECSP066411 A EC SP066411A
Authority
EC
Ecuador
Prior art keywords
tienopirazoles
tienopyrazoles
itk
inhibition
modulated
Prior art date
Application number
EC2006006411A
Other languages
English (en)
Inventor
John Gerard Jurcak
Matthieu Barrague
Timothy Alan Gillespy
Michael Louis Edwards
Kwon Yon Musick
Philip Marvin Weintraub
Yan Du
Ramalinga M Dharanipragada
Ashfaq Ahmed Parkar
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of ECSP066411A publication Critical patent/ECSP066411A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Tienopirazoles, su preparación, composiciones farmacéuticas que comprenden estos compuestos, y sus usos farmacéuticos en el tratamiento de estados de enfermedad capaces de ser modulados por la inhibición de las proteína quinasas, en particular la tirosina quinasa inducible por interleuquina-2 (ITK).
EC2006006411A 2003-09-08 2006-03-06 Tienopirazoles ECSP066411A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50115903P 2003-09-08 2003-09-08

Publications (1)

Publication Number Publication Date
ECSP066411A true ECSP066411A (es) 2006-09-18

Family

ID=34312256

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006411A ECSP066411A (es) 2003-09-08 2006-03-06 Tienopirazoles

Country Status (29)

Country Link
US (2) US7518000B2 (es)
JP (1) JP4879739B2 (es)
KR (1) KR20060069490A (es)
CN (1) CN100398545C (es)
AT (1) ATE468341T1 (es)
AU (1) AU2004272507B2 (es)
BR (1) BRPI0414215A (es)
CA (1) CA2538032C (es)
CR (1) CR8255A (es)
DE (1) DE602004027288D1 (es)
DK (1) DK1682553T3 (es)
EC (1) ECSP066411A (es)
ES (1) ES2345257T3 (es)
HR (1) HRP20100398T1 (es)
IL (1) IL173916A (es)
MA (1) MA28038A1 (es)
ME (1) MEP20908A (es)
MX (1) MXPA06001827A (es)
MY (1) MY144339A (es)
NO (1) NO20061626L (es)
NZ (1) NZ545421A (es)
OA (1) OA13252A (es)
PT (1) PT1682553E (es)
RS (2) RS51846B (es)
RU (1) RU2358978C2 (es)
TN (1) TNSN06058A1 (es)
TW (1) TWI352705B (es)
WO (1) WO2005026175A1 (es)
ZA (1) ZA200601947B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006101454A1 (en) * 2005-03-21 2006-09-28 S*Bio Pte Ltd Benzothiophene derivatives: preparation and pharmaceutical applications
WO2007076228A2 (en) * 2005-12-20 2007-07-05 Boehringer Ingelheim International Gmbh 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders
EP2151433A1 (en) 2008-08-05 2010-02-10 Institut Pasteur Alkoxypyrazoles and the process for their preparation
EP2151434A1 (en) 2008-08-05 2010-02-10 Institut Pasteur Alkoxypyrazoles and the process for their preparation
US8299070B2 (en) * 2009-11-25 2012-10-30 Japan Tobacco Inc. Indole compounds and pharmaceutical use thereof
US20130158066A1 (en) * 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 4-azaindole inhibitors of crac
WO2013153539A1 (en) 2012-04-13 2013-10-17 Glenmark Pharmaceuticals S.A. Tricyclic compounds as tec kinase inhibitors
CN103467481B (zh) * 2012-06-07 2016-08-31 上海汇伦生命科技有限公司 二氢吡啶类化合物、其组合物、制备方法和用途
TW201414734A (zh) 2012-07-10 2014-04-16 Takeda Pharmaceutical 氮雜吲哚衍生物
WO2014041518A1 (en) * 2012-09-14 2014-03-20 Glenmark Pharmaceuticals S.A. Thienopyrrole derivatives as itk inhibitors
CN103720694A (zh) * 2012-10-11 2014-04-16 韩冰 一类治疗脑性瘫痪的化合物及其用途
CN103772391A (zh) * 2012-10-23 2014-05-07 杨子娇 一类治疗房角狭窄的化合物及其用途
KR101571590B1 (ko) * 2012-11-21 2015-11-25 주식회사 두산 유기 화합물 및 이를 이용하는 유기 전계 발광 소자
EP3060218A4 (en) 2013-10-25 2017-07-19 Pharmacyclics LLC Methods of treating and preventing graft versus host disease
AR099052A1 (es) 2014-01-09 2016-06-29 Takeda Pharmaceuticals Co Derivados de azaindol
WO2016010108A1 (ja) * 2014-07-18 2016-01-21 塩野義製薬株式会社 含窒素複素環誘導体およびそれらを含有する医薬組成物
HK1256718A1 (zh) 2015-08-31 2019-10-04 药品循环有限责任公司 用於治疗多发性骨髓瘤的btk抑制剂组合
US20190298772A1 (en) 2016-11-03 2019-10-03 Juno Therapeutics, Inc. Combination therapy of a t cell-based therapy and a btk inhibitor
EP3787751A1 (en) 2018-05-03 2021-03-10 Juno Therapeutics, Inc. Combination therapy of a chimeric antigen receptor (car) t cell therapy and a kinase inhibitor
WO2023139248A1 (en) * 2022-01-21 2023-07-27 Ecole Polytechnique Federale De Lausanne (Epfl) Inhibitors of acyl protein thioesterases against microbial infections
US20250302954A1 (en) 2022-05-11 2025-10-02 Celgene Corporation Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy
WO2024123175A1 (en) 2022-12-06 2024-06-13 Erasmus University Medical Center Rotterdam Compositions for treating immune checkpoint blockade therapy resistant cancers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654307A (en) * 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
US6462036B1 (en) * 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
US6297238B1 (en) * 1999-04-06 2001-10-02 Basf Aktiengesellschaft Therapeutic agents
PT1194425E (pt) * 1999-06-23 2005-10-31 Aventis Pharma Gmbh Benzimidazoles substituidos
YU54202A (sh) * 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
US7101884B2 (en) * 2001-09-14 2006-09-05 Merck & Co., Inc. Tyrosine kinase inhibitors
FR2831536A1 (fr) * 2001-10-26 2003-05-02 Aventis Pharma Sa Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
MXPA04003954A (es) * 2001-10-26 2004-11-29 Aventis Pharma Inc Bencimidazoles.

Also Published As

Publication number Publication date
JP4879739B2 (ja) 2012-02-22
PT1682553E (pt) 2010-07-29
HRP20100398T1 (hr) 2010-09-30
IL173916A (en) 2011-07-31
RU2358978C2 (ru) 2009-06-20
KR20060069490A (ko) 2006-06-21
US20070254937A1 (en) 2007-11-01
TW200519118A (en) 2005-06-16
RS51846B (sr) 2012-02-29
BRPI0414215A (pt) 2006-11-07
CN1849322A (zh) 2006-10-18
CA2538032A1 (en) 2005-03-24
MEP20908A (en) 2010-06-10
ES2345257T3 (es) 2010-09-20
US7928231B2 (en) 2011-04-19
RU2006111470A (ru) 2007-10-27
TNSN06058A1 (en) 2007-10-03
CR8255A (es) 2006-07-14
ZA200601947B (en) 2007-05-30
DK1682553T3 (da) 2010-08-23
CN100398545C (zh) 2008-07-02
DE602004027288D1 (en) 2010-07-01
ATE468341T1 (de) 2010-06-15
CA2538032C (en) 2011-01-11
IL173916A0 (en) 2006-07-05
NO20061626L (no) 2006-04-10
AU2004272507B2 (en) 2011-05-12
JP2007505038A (ja) 2007-03-08
WO2005026175A1 (en) 2005-03-24
OA13252A (en) 2007-01-31
HK1095587A1 (zh) 2007-05-11
AU2004272507A1 (en) 2005-03-24
RS20060162A (sr) 2008-06-05
TWI352705B (en) 2011-11-21
NZ545421A (en) 2010-03-26
MY144339A (en) 2011-08-29
US20100056514A1 (en) 2010-03-04
US7518000B2 (en) 2009-04-14
MXPA06001827A (es) 2006-05-31
MA28038A1 (fr) 2006-07-03

Similar Documents

Publication Publication Date Title
ECSP066411A (es) Tienopirazoles
CR9591A (es) Inhibidores de proteina cinasa derivados de pirrol (2,3-b) piridina
ECSP099357A (es) COMPUESTOS QUE MODULAN ACTIVIDAD C-FMS y/o C-KIT Y USOS PARA ELLO
EE200300475A (et) Türosiini kinaasi inhibiitorid, neid sisaldavad ravimkoostised ja nimetatud ühendid kasutamiseks haiguste ravis
BRPI0509369A (pt) azaindóis úteis como inibidores de jak e outras proteìna cinases
SV2005002148A (es) "compuestos moduladores de la actividad c-kit y usos de los mismos"
BRPI0509172A (pt) pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE469151T1 (de) Pyrrolopyridinderivate als proteinkinaseinhibitoren
ECSP088350A (es) Pirazolopirimidinas como inhibidores de protein quinasas
BG66080B1 (bg) Заместени тиоацетамиди
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
NO20071078L (no) Antivirale forbindelser
ATE554087T1 (de) Neue kinaseinhibitoren
DK1423384T3 (da) Pyridinderivater som Raf kinaseinhibitorer
SV2004001555A (es) Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos
ECSP11005642A (es) Nuevos pirazolopirimidinas como inhibidores de quinasa dependientes de ciclinas
CL2007001748A1 (es) Compuesto derivado de 2-arilamino-4-aminopirimidinas, inhibidores de la proteina quinasa c-alfa; composiciones farmaceuticas que los contienen; y su uso para tratar o prevenir la diabetes, el cancer, enfermedades cardiovasculares y otras.
NO20060808L (no) Andvendelse av en PAK-inhibitorer for behandling av en leddsykdom
PT1282418E (pt) Utilizacao de derivados pirazolo para o tratamento da infertilidade
AR046672A1 (es) Prevencion y tratamiento de enfermedaes cardiacas hipertensivas mediante el uso de los estrogenos selectivos 8beta-vinil-estra-1,3,5(10)-trien-3,17beta-diol y 17beta-fluor-9alfa-vinil-estra-1,3,6(10)-trien-3,16alfa-diol
DK1331940T3 (da) Anvendelse af det lange pentraxin PTX3 til behandling af sygdomme forårsaget af ændret aktivering af vækstfaktoren FGF-2
UY26911A1 (es) Ácidos amino (oxo) acéticos inhibidores de la proteina tirosina fosfatasa
NO20051301L (no) Proteintyrosinforfataseinhibitorer